National Bank of Canada
REGN icon

National Bank of Canada’s Regeneron Pharmaceuticals REGN Stock Holding History

National Bank of Canada’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100M Buy
130,006
+10,194
+9% +$7.8M 0.09% 184
2025
Q4 		$92.5M Sell
119,812
-44,573
-27% -$30.3M 0.08% 197
2025
Q3 		$92.4M Buy
164,385
+21,573
+15% +$12.2M 0.09% 189
2025
Q2 		$75M Buy
142,812
+44,828
+46% +$25M 0.07% 227
2025
Q1 		$62.1M Sell
97,984
-5,667
-5% -$3.9M 0.07% 261
2024
Q4 		$73.8M Buy
103,651
+32,492
+46% +$27.3M 0.08% 237
2024
Q3 		$74.8M Buy
71,159
+28,365
+66% +$31.6M 0.09% 217
2024
Q2 		$45.2M Sell
42,794
-2,347
-5% -$2.28M 0.06% 243
2024
Q1 		$44M Sell
45,141
-71,086
-61% -$67.6M 0.07% 250
2023
Q4 		$105M Buy
116,227
+71,838
+162% +$59.2M 0.17% 131
2023
Q3 		$36.3M Buy
44,389
+6,315
+17% +$4.96M 0.06% 292
2023
Q2 		$27.3M Buy
38,074
+22,875
+151% +$17.6M 0.05% 288
2023
Q1 		$12.5M Buy
15,199
+773
+5% +$583K 0.03% 379
2022
Q4 		$10.4M Buy
14,426
+5,036
+54% +$3.72M 0.03% 419
2022
Q3 		$6.55M Sell
9,390
-1,059
-10% -$667K 0.04% 457
2022
Q2 		$6.18M Buy
10,449
+3,448
+49% +$2.24M 0.03% 499
2022
Q1 		$4.93M Sell
7,001
-1,318
-16% -$834K 0.01% 608
2021
Q4 		$5.23M Buy
+8,319
New +$5.11M 0.02% 551

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

National Bank of Canada's REGN Position: Q1 2026 in Review

National Bank of Canada increased its Regeneron Pharmaceuticals (REGN) stake by 8.5% in Q1 2026, buying an estimated $7.8M and bringing the position to 130,006 shares worth $100M. The position accounts for 0.09% of the portfolio, ranked #184.

National Bank of Canada first reported a position in REGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $105M in Q4 2023. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • National Bank of Canada held 130,006 shares of Regeneron Pharmaceuticals worth $100M as of Q1 2026.
  • National Bank of Canada bought 10,194 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $7.8M.
  • Regeneron Pharmaceuticals made up 0.09% of National Bank of Canada's portfolio in Q1 2026, its #184 holding.
  • National Bank of Canada first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Regeneron Pharmaceuticals position peaked at $105M in Q4 2023.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.